WHO ICTRP trial
To evaluate the safety and efficacy of M3D Fractional - Made By Medaria in…
IRCT201507226135N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201507226135N5 |
|---|---|
| Public title | To evaluate the safety and efficacy of M3D Fractional - Made By Medaria in reducing facial aging |
| Scientific title | To evaluate the safety and efficacy of M3D Fractional - Made By Medaria in reducing facial aging: A single arm phase III clinical trial |
| Primary sponsor | Medaria Company |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Facial aging. |
| Interventions | Each patient will receive six sessions of m3D Fractional treatment to the whole face. The face will be thoroughly cleaned and dried before treatment. Treatment will be conducted by trained and experienced technician according to the… |
| Registration date | Jul 24, 2015 |
| Target size | 15 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: